Basal Cell Carcinoma
There are many excellent methods for the effective treatment of a primary basal cell carcinoma (BCC), the most common of which are (1) curettage and electrodesiccation (C and D), (2) cryosurgery using liquid nitrogen (3) radiation therapy, and (4) surgical excision with primary closure or resurfacing using skin flaps or skin grafts (1–9). The choice of initial therapy for a BCC depends on numerous factors, including its anatomic location, size, clinical characteristics, histologic features, age and medical condition of the patient, anticipated cosmetic result, previous treatment history, and comfort, duration, and cost of treatment. It has been reported that the cure rates with each of the four standard modalities mentioned above approach 95% for simple, primary BCC. Although all of these methods can effectively destroy BCC, in certain situations one method may be preferable to the others.
KeywordsArsenic Neuropathy Interferon Doxorubicin Methotrexate
Unable to display preview. Download preview PDF.
- 2.Cottel WI (1986) Skin tumors I: Basal and squamous cell carcinomas. Sel Read Plast Surg 4 (6): 6–22Google Scholar
- 3.Haynes HA, Mead KW, Goldwyn RM (1985) Cancers of the skin. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: Principles and practice of oncology, 2nd edn. Lippincott, Philadelphia, pp 1343–1369Google Scholar
- 6.Witkowski JA, Parish LC (1982) Basal cell cancer: a curable malignancy. Drug Ther 12(11): 159–161, 164–165Google Scholar
- 9.Helm F (ed) (1979) Cancer dermatology. Lea and Febiger, Philadelphia, pp 325–481Google Scholar
- 10.Epstein E (ed) (1984) Controversies in dermatology. Saunders, Philadelphia, pp 107–133, 163–184Google Scholar
- 11.Peck GL (1985) Therapy and prevention of skin cancer. In: Saurat JH (ed) Retinoids: new trends in research and therapy. Karger, Basel, pp 345–354Google Scholar